These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30850252)

  • 1. Impact of syndrome-specific antimicrobial stewardship interventions on use of and resistance to fluoroquinolones: An interrupted time series analysis.
    Hecker MT; Son AH; Murphy NN; Sethi AK; Wilson BM; Watkins RR; Donskey CJ
    Am J Infect Control; 2019 Aug; 47(8):869-875. PubMed ID: 30850252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis.
    Sarma JB; Marshall B; Cleeve V; Tate D; Oswald T; Woolfrey S
    J Hosp Infect; 2015 Sep; 91(1):74-80. PubMed ID: 26169793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.
    Shea KM; Hobbs ALV; Jaso TC; Bissett JD; Cruz CM; Douglass ET; Garey KW
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing Fluoroquinolone Use and Clostridioides difficile Infections in Community Nursing Homes Through Hospital-Nursing Home Collaboration.
    Felsen CB; Dodds Ashley ES; Barney GR; Nelson DL; Nicholas JA; Yang H; Aydelotte ME; Karlic A; Nicholas NC; Petrone KK; Pine RD; Schabel SL; Medina-Walpole A; Dumyati GK
    J Am Med Dir Assoc; 2020 Jan; 21(1):55-61.e2. PubMed ID: 31888865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in resistance among coliform bacteraemia associated with a primary care antimicrobial stewardship intervention: A population-based interrupted time series study.
    Hernandez-Santiago V; Davey PG; Nathwani D; Marwick CA; Guthrie B
    PLoS Med; 2019 Jun; 16(6):e1002825. PubMed ID: 31173597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
    Vaughn VM; Gandhi T; Conlon A; Chopra V; Malani AN; Flanders SA
    Clin Infect Dis; 2019 Sep; 69(8):1269-1277. PubMed ID: 30759198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience.
    Lee RA; Scully MC; Camins BC; Griffin RL; Kunz DF; Moser SA; Hoesley CJ; McCarty TP; Pappas PG
    Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1419-1424. PubMed ID: 30296959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital.
    Zeana C; Palmieri FE; Gupta V; Ye G; Lao P; Yu K; Kang KS; Schiller L; Purswani M
    Sci Prog; 2021; 104(2):368504211011876. PubMed ID: 33908291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of control interventions on Clostridium difficile infection in England: an observational study.
    Dingle KE; Didelot X; Quan TP; Eyre DW; Stoesser N; Golubchik T; Harding RM; Wilson DJ; Griffiths D; Vaughan A; Finney JM; Wyllie DH; Oakley SJ; Fawley WN; Freeman J; Morris K; Martin J; Howard P; Gorbach S; Goldstein EJC; Citron DM; Hopkins S; Hope R; Johnson AP; Wilcox MH; Peto TEA; Walker AS; Crook DW;
    Lancet Infect Dis; 2017 Apr; 17(4):411-421. PubMed ID: 28130063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis.
    Sarma JB; Marshall B; Cleeve V; Tate D; Oswald T; Woolfrey S
    J Hosp Infect; 2015 Sep; 91(1):68-73. PubMed ID: 26122624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in antibiotic consumption, AMR and Clostridioides difficile infections in a large tertiary-care center following the implementation of institution-specific guidelines for antimicrobial therapy: A nine-year interrupted time series study.
    Schönherr SG; Ranft D; Lippmann N; Lübbert C
    PLoS One; 2021; 16(10):e0258690. PubMed ID: 34648594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
    Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain.
    Arca-Suárez J; Galán-Sánchez F; Cano-Cano F; García-Santos G; Rodríguez-Iglesias MA
    Anaerobe; 2018 Dec; 54():146-150. PubMed ID: 30261271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
    DiDiodato G; McArthur L
    PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile.
    Dingle KE; Freeman J; Didelot X; Quan TP; Eyre DW; Swann J; Spittal WD; Clark EV; Jolley KA; Walker AS; Wilcox MH; Crook DW
    mBio; 2023 Apr; 14(2):e0024323. PubMed ID: 37017518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an automatic discontinuation of antibiotics policy: A novel approach to antimicrobial stewardship.
    Bolten BC; Bradford JL; White BN; Heath GW; Sizemore JM; White CE
    Am J Health Syst Pharm; 2019 Sep; 76(Supplement_3):S85-S90. PubMed ID: 31418771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.
    Talpaert MJ; Gopal Rao G; Cooper BS; Wade P
    J Antimicrob Chemother; 2011 Sep; 66(9):2168-74. PubMed ID: 21676904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study.
    Lafaurie M; Porcher R; Donay JL; Touratier S; Molina JM
    J Antimicrob Chemother; 2012 Apr; 67(4):1010-5. PubMed ID: 22240401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unnecessary use of fluoroquinolone antibiotics in hospitalized patients.
    Werner NL; Hecker MT; Sethi AK; Donskey CJ
    BMC Infect Dis; 2011 Jul; 11():187. PubMed ID: 21729289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.